Profil
Ms. Hema Keshava is a Senior Vice President-Finance at Abivax SA and a Corporate Controller at CinCor Pharma, Inc.
Postes actifs de Hema Keshava
Sociétés | Poste | Début |
---|---|---|
CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2021 |
ABIVAX | Corporate Officer/Principal | 01/07/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ABIVAX | Health Technology |
Entreprise privées | 1 |
---|---|
CinCor Pharma, Inc.
CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |